| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2006;114:1360-1371.)
© 2006 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
From the Cardiovascular Research Group (S.Y., H.D., M.R.B.), School of Medicine, University of Manchester, Core Technology Facility, Manchester, United Kingdom; Washington University (V.V.F., V.P.N., I.R.E.), St Louis, Mo; Postgraduate Medical Institute and Hull York Medical School (S.-Z.X.), University of Hull, Hull, United Kingdom; Kagawa Prefectural College of Health Science (T.T.Y.), Kagawa, Japan; School of Biomedical Sciences, University of Leeds (S.A.J.), Leeds, United Kingdom; and Research Institute of Environmental Medicine (M.Y.), Nagoya University, Nagoya, Japan.
Correspondence to Professor M.R. Boyett, Cardiovascular Research Group, School of Medicine, University of Manchester, Core Technology Facility, 46 Grafton St, Manchester M13 9NT, United Kingdom. E-mail mark.boyett{at}manchester.ac.uk
Received January 13, 2006; revision received July 7, 2006; accepted July 13, 2006.
| Abstract |
|---|
|
|
|---|
Methods and Results The rat AVN was identified by Massons trichrome staining together with immunolabeling of marker proteins: connexin40, connexin43, desmoplakin, atrial natriuretic peptide, and hyperpolarization-activated and cyclic nucleotidegated channel 4. Na+ channel expression was investigated with immunohistochemistry with isoform-specific Na+ channel antibodies. Nav1.1 was distributed in a similar manner to Nav1.5. Nav1.2 was not detected. Nav1.3 labeling was present in nerve fibers and cell bodies (but not myocytes) and was abundant in the penetrating atrioventricular (AV) bundle and the common bundle but was much less abundant in other regions. Nav1.5 labeling was abundant in the atrial and ventricular myocardium and the left bundle branch. Nav1.5 labeling was absent in the open node, penetrating AV bundle, AV ring bundle, and common bundle but present at a reduced level in the inferior nodal extension and transitional zone. Nav1.6 was not detected.
Conclusions Our findings provide molecular evidence of multiple electrophysiological cell types at the AV junction. Impaired AV conduction as a result of mutations in or loss of Nav1.5 must be the result of impaired conduction in the AVN inputs (inferior nodal extension and transitional zone) or output (bundle branches) rather than the AVN itself (open node and penetrating AV bundle).
Key Words: atrioventricular node conduction sodium channels connexins immunohistochemistry
| Introduction |
|---|
|
|
|---|
Clinical Perspective p 1371
| Methods |
|---|
|
|
|---|
50°C in isopentane cooled by liquid N2 and stored at 80°C until use. The frozen preparations were secured on the chuck of a cryostat (CM 1850; Leica Microsystems GmbH, Bensheim, Germany) with Jung tissue-freezing medium and serially sectioned (at 15°C) at 10-µm thickness perpendicular to the AV junction. Sets of sections were collected at
500-µm intervals from the coronary sinus to the common bundle. Sections were mounted on Superfrost Plus slides (BDH, Poole, United Kingdom) and stored at 80°C until use. Some sections were stained with Massons trichrome as described previously.12 Others sections were immunolabeled (as described previously13) for 5 Na+ channel isoforms (Nav1.1, Nav1.2, Nav1.3, Nav1.5, and Nav1.6) and 5 marker proteins: connexin40 (Cx40), connexin43 (Cx43), desmoplakin I/II (DP), atrial natriuretic peptide (ANP), and hyperpolarization-activated and cyclic nucleotidegated channel 4 (HCN4). Data for Nav1.1, Nav1.3, Nav1.5, Cx43, DP, ANP, and HCN4 from 1 preparation are shown in Figures 1 through 8
|
|
|
|
|
|
|
|
The authors had full access to the data and take full responsibility for their integrity. All authors have read and agree to the manuscript as written.
| Results |
|---|
|
|
|---|
500-µm intervals. The position of the 14 sets of sections in 1 preparation is shown in Figure 1A. Data for Cx43, DP, ANP, HCN4, Nav1.1, Nav1.3, and Nav1.5 from the preparation shown in Figure 1A are shown in Figures 1 through 8
Inferior Nodal Extension
Nomenclature used for the AV junction follows the recommendations of Cosio et al.17 Figures 2 through 4![]()
show labeling at the level of the inferior nodal extension (Figure 1A, level 4). Figure 2A shows a Massons trichromestained section (connective tissue is stained blue, and myocytes are stained red). The inferior nodal extension is outlined in Figure 2A (and all other panels in Figures 2 and 4
). The inferior nodal extension was in close proximity to the atrial muscle but separated from the ventricular muscle by connective tissue and the tricuspid valve (Figure 2A). The myocytes in the inferior nodal extension were generally stained a lighter red than the surrounding atrial and ventricular muscle (Figure 2A). Figure 2B shows that DP (red signal) was expressed in all myocytes (at cell margin), including those of the inferior nodal extension; as expected, it was not expressed in connective tissue. Cx40 was not expressed in the inferior nodal extension (data not shown). Cx43 was expressed in the atrial and ventricular muscle (at intercalated discs) but not in the inferior nodal extension (eg, Figure 2B, green signal). Figure 2C shows that ANP (red signal) was expressed in the atrial muscle (present in intracellular vesicles) but not in the inferior nodal extension or ventricular muscle. Figure 2D shows that HCN4 (green signal) was expressed in the inferior nodal extension (at the cell membrane; there was also intracellular labeling) but not in the atrial or ventricular muscle (dull green signal in the atrial and ventricular muscle in Figure 2D is background only). The unique pattern of expression in the inferior nodal extension (DP-positive/Cx43-negative/ANP-negative/HCN4-positive) allowed it to be distinguished from the nearby atrial muscle (DP-positive/Cx43-positive/ANP-positive/HCN4-negative). Figure 3 shows high-magnification images of Nav1.1 labeling (green signal) in different regions. Nav1.1 labeling was present in the atrial and ventricular muscle in the outer cell membrane; there was also a nonspecific labeling of nuclei (Figures 3A and 3G). Nav1.1 labeling was also present in the inferior nodal extension (Figure 3D). Figure 4 shows immunolabeling of Nav1.3 and Nav1.5 (green signal) at the inferior nodal extension. There was labeling of Nav1.3 (bright green labeling, some highlighted by arrows, in Figure 4A) but not in myocytes (dull green labeling in Figure 4A is background only). Nav1.3 colocalized with a neuronal cell marker, neurofilament 160 (Data Supplement Figure I), and this shows it to be present in nerve fibers/cell bodies. There was little or no innervation (as detected by Nav1.3 labeling) in the atrial and ventricular muscle, but there was innervation (relatively weak) in the inferior nodal extension (Figure 4A). There was dense labeling of Nav1.5 in the atrial and ventricular muscle (Figure 4B). There was labeling of Nav1.5, although weaker than in atrial and ventricular muscle, in the inferior nodal extension (Figure 4B). This was confirmed by semiquantitative assessment of Nav1.5 labeling (Data Supplement Figure II). As expected, there was no labeling of Nav1.5 in connective tissue (Figure 4B). Control experiments confirmed that the Nav1.5 antibody was specific (Data Supplement Figure III).
Penetrating AV Bundle
Continuous with the inferior nodal extension is the superior enclosed part of the AVN, described by Tawara2 as the penetrating AV bundle. Figures 5 and 6
show labeling at the level of the penetrating AV bundle (Figure 1A, level 9). At this level, the tissue architecture was more complex than at the inferior nodal extension. The penetrating AV bundle consisted of an ovoid group of myocytes, which were separated from the surrounding atrial and ventricular muscle by connective tissue (Figure 5A). The myocytes in the penetrating AV bundle were stained a lighter red than the surrounding atrial and ventricular muscle (Figure 5A) and were located in the center of the tissue. In addition to the myocytes of the penetrating AV bundle, there was another group of nodal-like myocytes above the tricuspid valve (Figure 5A). These myocytes will be referred to as "transitional myocytes" and together with the inferior nodal extension are part of a continuous structure around the tricuspid valve first described by Anderson18 (the AV ring bundle; see below). Once again, DP was expressed in all myocytes, including those in the penetrating AV bundle and the transitional zone (Figure 5B). Cx40 was expressed in the penetrating AV bundle, but only in the lower half (Data Supplement Figure IV). Cx43 was not detectable in the penetrating AV bundle or transitional zone (Figure 5B). ANP was not expressed (Figure 5C), whereas HCN4 was expressed (Figure 5D), in the penetrating AV bundle and transitional zone. There was no Nav1.1 labeling (apart from nonspecific labeling of nuclei) in the penetrating AV bundle (Figure 3E). Once again, Nav1.3 labeling was only observed in nerve fibers and cell bodies (Figure 6A). Innervation (as judged by Nav1.3 labeling) was abundant in the penetrating AV bundle (more abundant than in inferior nodal extension; Figure 6A). There was much less abundant innervation in the transitional zone (similar to that of the inferior nodal extension; Figure 6A). Figure 6B shows that there was no labeling of Nav1.5 in the penetrating AV bundle. In the transitional zone, there was labeling of Nav1.5; it was weaker than that in the atrial and ventricular muscle (as in the case of the inferior nodal extension). This was confirmed by semiquantitative assessment of Nav1.5 labeling (Data Supplement Figure II).
Common Bundle
Figures 7 and 8
show labeling at the level of the common bundle (Figure 1A, level 11). At this level, the tissue architecture was even more complex. The common bundle consisted of a triangle of pale redstaining myocytes, which were separated from surrounding atrial and ventricular myocytes by connective tissue (Figure 7A). At this level, the zone of transitional myocytes was again present (Figure 7A), but it was smaller than at the level of the penetrating AV bundle (Figure 5A). In addition, there was another region of nodal-like myocytes (Figure 7A), and this we refer to as the termination of the tricuspid valve AV ring bundle (it is not, however, the termination of the tract of nodal-like myocytes; see below). This region of nodal-like myocytes lies above, but separate from, the transitional zone (Figure 7A). Once again, DP was expressed in all myocytes, including those in the common bundle, transitional zone, and termination of the AV ring bundle (Figure 7B). Cx40 was expressed throughout the common bundle (Data Supplement Figure V). Weak punctuate labeling of Cx43 was present in the common bundle, but Cx43 was not detectable in the transitional zone and termination of the AV ring bundle (Figure 7C). ANP was expressed in the atrial muscle but not elsewhere (Figure 7C), whereas HCN4 was expressed in the common bundle, transitional zone, and termination of the AV ring bundle (Figure 7D). There was no Nav1.1 labeling (apart from nonspecific labeling of nuclei) in the common bundle (Figure 3F) or the termination of the AV ring bundle (Figure 3C), whereas there was labeling in the transitional zone (Figure 3B). Labeling of Nav1.3 (once again in nerve fibers and cell bodies) was abundant in the common bundle and was present but much less abundant in the transitional zone, and there was little or no labeling in the termination of the AV ring bundle (Figure 8A). Nav1.5 labeling was present but less abundant (than in atrial and ventricular muscle) in the transitional zone and absent from the common bundle and termination of the AV ring bundle (Figure 8B); this was confirmed by semiquantitative assessment of Nav1.5 labeling (Data Supplement Figure II).
Left Bundle Branch
In the left bundle branch, as in the common bundle, Cx40 and HCN4, but not Cx43, were expressed (Data Supplement Figure V). Whereas Nav1.5 was not expressed in the common bundle, it was expressed in the left bundle branch, 1.5 mm from the common bundle (Data Supplement Figures II and V). DP and Nav1.1 were expressed, whereas Nav1.3 was not expressed in the left bundle branch (data not shown). Strikingly, ANP was expressed in the left bundle branch (data not shown). The right bundle branch was not investigated.
Around the Tricuspid Annulus
Nodal/nodal-like myocytes are not confined to the triangle of Koch and continue as the AV ring bundle around the tricuspid valve.18 The expression pattern in the AV ring bundle on the opposite side of the tricuspid valve to the AVN was the same as that of the transitional zone but different from that of the common bundle: DP-positive (data not shown), Cx40-negative (data not shown), Cx43-negative (Data Supplement Figure VI), ANP-negative (data not shown), HCN4-positive (Data Supplement Figure VI), Nav1.1-positive (Data Supplement Figure VII), Nav1.3-positive (data not shown), and Nav1.5-positive (Data Supplement Figure VII).
Summary
The Table summarizes the expression pattern in the different tissues. On the basis of the expression pattern, 3 types of nodal/nodal-like myocytes were identified: ring bundle myocytes were present in the inferior nodal extension, the transitional zone, and the AV ring bundle on the opposite side of the tricuspid valve to the AVN; nodal myocytes were expressed in the open node (nodal tissue immediately proximal to the penetrating AV bundle), the penetrating AV bundle, and the termination of the AV ring bundle; and His bundle myocytes only differed from nodal myocytes in their expression of Cx40 and were located in the penetrating AV bundle (lower part), common bundle, and bundle branches.
|
For all 14 levels investigated from the preparation shown in Figure 1A, Massons trichromestained sections are shown in Figure VIII of the Data Supplement, and the distribution of the different tissues and the 3 types of nodal/nodal-like myocytes is summarized in Figure 1C. The distribution of the 3 types of nodal/nodal-like myocytes (from Figure 1C) was mapped onto the original preparation (Figure 1A). Figure 1A shows the following: ring bundle myocytes (light blue) in the inferior nodal extension continued as the transitional zone adjacent to the open node; nodal myocytes (green) in the open node projected into the penetrating AV bundle; nodal myocytes (green) were also present in the termination of the AV ring bundle; and His bundle myocytes (purple) starting in the lower part of the penetrating AV bundle continued in the common bundle. Figure 1B shows a schematic of the whole of the tricuspid valve AV ring bundle. Figure 1B shows that the penetrating AV bundle, transitional zone, and inferior nodal extension are just 1 part of the AV ring bundle that projects around the tricuspid valve. Whereas much of the AV ring bundle is made up of ring bundle myocytes, the termination of the tricuspid valve AV ring bundle (above the AVN) comprises nodal myocytes. Figure 1B shows that the termination of the tricuspid valve AV ring bundle is not the termination of the tract of nodal/nodal-like myocytes; it continues as the mitral valve ring bundle.
Previously, we have shown (using optical recordings of action potentials) that in the rabbit, pacemaker activity at the AV junction originates in the inferior nodal extension.19 In similar experiments, we observed that in the rat, pacemaker activity at the AV junction also originates in the region of the inferior nodal extension. From the leading pacemaker site, the action potential propagated at a slow velocity (4 to 12 cm/s) along a discrete pathway (the slow pathway) before exiting into the atrial muscle (data not shown). The approximate position of the slow pathway as defined by these experiments corresponds to the inferior nodal extension.
| Discussion |
|---|
|
|
|---|
Relation to Previous Studies
Petrecca et al20 previously reported evidence of a lower level of expression of Nav1 in the mid-nodal cells of the rabbit AVN and the results of the present study from the rat AVN are consistent with this. But Petrecca et al20 used an antibody raised against a conserved region of the Nav1 subfamily (the antibody, therefore, could not discriminate between different Na+ channel isoforms); there have been no previous studies using antibodies for specific Na+ channel isoforms. In the present study, the labeling of HCN4 in the rat AVN is similar to that in the rabbit AVN reported by Dobrzynski et al.13 Ko et al21 reported that Cx43 is expressed in the inferior nodal extension in the rabbit, whereas in the present study of the rat and in a study by Dobrzynski et al13 of the rabbit, the inferior nodal extension was Cx43-negative. This discrepancy is likely to be the result of confused nomenclature only; the "inferior nodal extension" in the study of Ko et al21 probably corresponds to the tract of Cx40-expressing (in the rat; Data Supplement Figure IV) or Cx43-expressing (in the rabbit; unpublished observations) His bundle myocytes. Above the "inferior nodal extension" in the study by Ko et al,21 there is a tract of Cx43-negative myocytes (termed "transitional cells" by Ko et al21), and this corresponds to the inferior nodal extension in the present study (Figure 1) and the study by Dobrzynski et al.13
Electrophysiologically, 3 types of myocytes have been identified at the AV junction (atrionodal [AN], N [nodal], and nodo-His [NH] myocytes),18,22 and it is tempting to speculate that they may be related to the 3 types of nodal/nodal-like myocytes identified in the present study. In the rabbit, whereas atrial myocytes have an upstroke velocity of >100 V/s, the upstroke velocity of AN (ANCO and ANL), N, and NH myocytes is
48, 18, and 17 V/s, respectively.22 In comparison, in the present study, the intensity of Nav1.5 labeling in atrial myocytes was 79±5% (of labeling in ventricular myocytes), whereas the intensity of Nav1.5 labeling in ring bundle myocytes, nodal myocytes, and His bundle myocytes was 34±5/39±4% (inferior nodal extension/transitional zone), 18±6/14±3% (open node/termination of AV ring bundle), and 24±7% (common bundle), respectively (Data Supplement Figure II). At the level of the penetrating AV bundle and common bundle, there was a second group of nodal-like myocytes, and these were referred to as transitional myocytes (although they were indistinguishable from the nodal-like myocytes of the inferior nodal extension). These nodal-like myocytes (ring bundle myocytes) are transitional in that although atrial myocytes show abundant expression of Nav1.1 and Nav1.5 and nodal myocytes in the penetrating AV bundle show no expression, they show an intermediate level of expression (Data Supplement Figure II). In the rabbit, transitional myocytes (with a transitional histological appearance and presumed to be AN myocytes) have also been identified.18,22
Understanding the Electrophysiology of the AV Junction
The AVN has dual inputs (slow and fast pathways) from the atrial myocardium, and this is the substrate for AVN reentry.23 The slow pathway proceeds parallel to the tricuspid valve annulus from beneath the coronary sinus to the penetrating AV bundle near the apex of the triangle of Koch, whereas the fast pathway enters the penetrating AV bundle superiorly from the direction of the atrial septum. The results from the present study help to understand this dual-pathway electrophysiology and other aspects of the electrophysiology of the AV junction.24,25
In the atrial (and ventricular) myocardium, the upstroke velocity (100 to 160 V/s) and amplitude (90 to 110 mV) of the action potential are high,22,26 and this is because the voltage-dependent Na+ current, INa, is responsible for it. In accordance with this, in the present study, we observed labeling of both Nav1.5 and Nav1.1 in the atrial myocardium (eg, Figures 3 and 6
and Figure II in the Data Supplement). The high conduction velocity in atrial myocardium (eg, 70 cm/s1) can be explained by the high upstroke velocity of the action potential (as a result of the expression of Nav1.5 and Nav1.1) and the abundant expression of the medium conductance gap junction protein, Cx43 (for example, in Figure 5) in the atrial myocardium.
In the slow pathway, the upstroke velocity and amplitude of the action potential have been reported to be intermediate between those in the atrial myocardium and the penetrating AV bundle (41 V/s and 70 mV, respectively26). Consistent with this, in the present study, we observed labeling of both Nav1.5 and Nav1.1 in the inferior nodal extension, but the labeling of Nav1.5 was less abundant than in the atrial myocardium (Figures 3D and 4
B and Figure II in the Data Supplement). The low conduction velocity of the slow pathway/inferior nodal extension (4 to 12 cm/s in the present study; 7 to 8 cm/s in the study by Nikolski et al19) could be the result of the reduced expression of Nav1.5. It could also be the result of the lack of expression of the medium and high conductance gap junction proteins, Cx43 and Cx40, in the inferior nodal extension (Cx45 is expressed instead13).
The location of the transitional zone means that it could be the fast pathway into the penetrating AV bundle from the direction of the atrial septum. In the fast pathway (and AN cells), the upstroke velocity (40 to 60 V/s) and amplitude (70 to 80 mV) of the action potential are again intermediate between those in the atrial myocardium and the penetrating AV bundle.22,26 Consistent with this, we observed labeling of both Nav1.5 and Nav1.1 in the transitional zone, but the labeling of Nav1.5 was less abundant than in the atrial muscle (Figures 3B and 6
B and Figure II in the Data Supplement). Conduction time via the fast pathway is shorter than that via the slow pathway. If the transitional zone does constitute the fast pathway, the difference in conduction time between the slow and fast pathways (ie, between inferior nodal extension and transitional zone) is unlikely to be the result of differences in the expression of Na+ channels or connexins (because expression in the 2 regions was similar; Table). Instead, the shorter conduction time via the fast pathway is perhaps the result of the shortness (
1 mm) of the tract of Cx43-negative myocytes with reduced Nav1.5 expression in the transitional zone that the action potential has to propagate across to reach the open node (the length of the slow pathway/inferior nodal extension is much greater; Figure 1A).
In the penetrating AV bundle (and N cells), in contrast to atrial muscle, the upstroke velocity (18 V/s) and amplitude (50 to 80 mV) of the action potential are low,26 and this is because the L-type Ca2+ current, ICa,L, rather than INa, is responsible for it. In cells likely to be from the penetrating AV bundle, there is no INa.20 Consistent with this, we observed no labeling of either Nav1.5 or Nav1.1 in the penetrating AV bundle (Figures 3E and 6
B and Figure II in the Data Supplement). The absence of Nav1.5 or Nav1.1 expression continued from the open node, through the penetrating AV bundle and common bundle to the proximal left (and presumably right) bundle branch. Consistent with this, in the NH cells in this region, the upstroke velocity (20 to 30 V/s) and amplitude (60 to 80 mV) of the action potential are still low.26 Slow conduction through the AVN is responsible for the delay between activation of the atria and ventricles in the cardiac cycle, and the absence of Nav1.5 and Nav1.1 from the open node to the proximal left and right bundle branches will at least contribute to the slow conduction. However, the expression pattern of connexins is also expected to contribute: From the open node to the proximal left bundle branch, the medium conductance gap junction protein, Cx43, was not expressed or was poorly expressed (eg, Figure 6); however, from the penetrating AV bundle to the left bundle branch, the high-conductance gap junction protein, Cx40, was expressed (eg, Data Supplement Figure IV).
In the rabbit and dog, the upstroke velocity and amplitude of the action potential and conduction velocity are high in the common bundle,22,26 and this is inconsistent with the lack of expression of Nav1.5 and Nav1.1 in the common bundle in the rat (Figures 3F and 8
B and Figure II in the Data Supplement). It is possible that this reflects a species difference: Because a rat is
10 to 100 times smaller than a rabbit or dog, and yet the PR interval is approximately the same,27 it follows that Nav1.5 may be absent from a greater proportion of the AV conduction pathway. In the common bundle, Mazgalev et al24 have described distinct electrophysiologies in the mid and lower nodal myocytes. Does this correspond to the upper Cx40-negative and lower Cx40-positive nodal myocytes in the penetrating AV bundle in the rat, as shown in Figure IV of the Data Supplement?
The pattern of Nav1.3 labeling was different from the pattern of labeling of myocytes by other antibodies, but it was similar to that of neuronal tissue at the AV junction in the studies by Petrecca et al28 and Anderson.18 Furthermore, in the present study, Nav1.3 labeling was colocalized with labeling of the neuronal cell marker, neurofilament 160 (Data Supplement Figure I), and therefore, it is likely that Nav1.3 is expressed by neuronal tissue. Petrecca et al28 and Anderson18 showed that neuronal innervation is abundant in the nodal tissues at the AV junction (compared with the working myocardium). In the present study, Nav1.3 labeling was minimal in atrial and ventricular muscle, present (but not abundant) in the specialized pathways into the AVN (inferior nodal extension and transitional zone), and abundant in the open node and penetrating AV bundle. Therefore, innervation may be controlling AV conduction at the point at which conduction will be the most severely constrained by the absence of Nav1.5, Nav1.1, Cx40 (in part, at least), and Cx43 (to a large degree, at least). Interestingly, in humans, innervation is more abundant in the transitional zone than in the compact node and penetrating bundle.29
Why Do Mutations in or Knockout of Nav1.5 (SCN5A) Result in AV Conduction Defects?
The role of Nav1.5 in AV conduction has recently been highlighted by the discovery of inherited AV conduction disturbances (block or slowing of AV conduction) linked to mutations in SCN5A47 (responsible for Nav1.5) and the discovery that SCN5A+/ mice have impaired AV conduction.9 The present findings provide the substrate for these conduction disturbances. There is no Nav1.5 expressed in a long tract from the open node to the proximal part of the left and presumably right bundle branches (Figure 1); Nav1.5 is expressed, however, in the pathways into the open node (inferior nodal extension and transitional zone; Figure 1), although less abundantly than in the working myocardium (Data Supplement Figure II), and these are the most likely regions in which conduction defects will occur when Nav1.5 is impaired (because the safety factor for conduction is already likely to be low in these regions as a result of the lower expression of Nav1.5). This raises the possibility that the AV conduction abnormalities could be corrected by local upregulation of Nav1.5 (perhaps by local transfection with further copies of SCN5A). Alternatively (or as well), the AV conduction abnormalities could be the result of impaired conduction in the bundle branches, because the bundle branches do express Nav1.5 (Data Supplement, Figure V), and indeed, there is evidence of this.9
Conclusions
Recently, a 3-dimensional anatomic model of the human AVN has been generated on the basis of histological information only.30 Although an appreciation of the complex anatomy of the AV junction is important for the understanding of AV conduction, it is also important to understand the distribution of the proteins involved in the action potential and its conduction. Na+ channels play a major role in conduction, and this is the first study to map in detail the distribution of Na+ channels throughout the AV junction. The expression of Na+ channels was nonuniform at the AV junction and allowed the identification of various types of nodal/nodal-like myocytes.
| Acknowledgments |
|---|
This work was supported by the British Heart Foundation (grant No. RG/2001009 to Dr Boyett) and the British Council (grant no. GSET90 to Dr Yamanushi).
Disclosures
None.
| References |
|---|
|
|
|---|
2. Tawara S. The Conduction System in the Mammalian Heart: An Anatomic-Histological Study of the Atrioventricular Bundle and the Purkinje Fibers. Suma K, Shimada M, trans. London, UK: Imperial College Press; 2000.
3. Schram G, Pourrier M, Melnyk P, Nattel S. Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ Res. 2002; 90: 939950.
4. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, Wilde AA, Escande D, Mannens MM, Le Marec H. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet. 1999; 23: 2021.[Medline] [Order article via Infotrieve]
5. Lupoglazoff JM, Cheav T, Baroudi G, Berthet M, Denjoy I, Cauchemez B, Extramiana F, Chahine M, Guicheney P. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res. 2001; 89: E16E21.[CrossRef][Medline] [Order article via Infotrieve]
6. Kyndt F, Probst V, Potet F, Demolombe S, Chevallier JC, Baro I, Moisan JP, Boisseau P, Schott JJ, Escande D, Le Marec H. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation. 2001; 104: 30813086.
7. Tan HL, Bink-Boelkens MT, Bezzina CR, Viswanathan PC, Beaufort-Krol GC, van Tintelen PJ, van den Berg MP, Wilde AA, Balser JR. A sodium-channel mutation causes isolated cardiac conduction disease. Nature. 2001; 409: 10431047.[CrossRef][Medline] [Order article via Infotrieve]
8. Wang DW, Viswanathan PC, Balser JR, George AL Jr, Benson DW. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation. 2002; 105: 341346.
9. Papadatos GA, Wallerstein PM, Head CE, Ratcliff R, Brady PA, Benndorf K, Saumarez RC, Trezise AE, Huang CL, Vandenberg JI, Colledge WH, Grace AA. Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A. 2002; 99: 62106215.
10. Maier SK, Westenbroek RE, Schenkman KA, Feigl EO, Scheuer T, Catterall WA. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci U S A. 2002; 99: 40734078.
11. Maier SK, Westenbroek RE, Yamanushi TT, Dobrzynski H, Boyett MR, Catterall WA, Scheuer T. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A. 2003; 100: 35073512.
12. Bancroft JD, Gamble M. Theory and Practice of Histological Techniques. 5th ed. London, UK: Churchill Livingstone; 2002.
13. Dobrzynski H, Nikolski VP, Sambelashvili AT, Greener ID, Yamamoto M, Boyett MR, Efimov IR. Site of origin and molecular substrate of atrioventricular junctional rhythm in the rabbit heart. Circ Res. 2003; 93: 11021110.
14. Gros DB, Jongsma HJ. Connexins in mammalian heart function. Bioessays. 1996; 18: 719730.[CrossRef][Medline] [Order article via Infotrieve]
15. Gutstein DE, Liu FY, Meyers MB, Choo A, Fishman GI. The organization of adherens junctions and desmosomes at the cardiac intercalated disc is independent of gap junctions. J Cell Sci. 2003; 116: 875885.
16. Antunes-Rodrigues J, de Castro M, Elias LL, Valenca MM, McCann SM. Neuroendocrine control of body fluid metabolism. Physiol Rev. 2004; 84: 169208.
17. Cosio FG, Anderson RH, Kuck KH, Becker A, Borggrefe M, Campbell RW, Gaita F, Guiraudon GM, Haissaguerre M, Rufilanchas JJ, Thiene G, Wellens HJ, Langberg J, Benditt DG, Bharati S, Klein G, Marchlinski F, Saksena S. Living anatomy of the atrioventricular junctions: a guide to electrophysiologic mapping: a consensus statement from the Cardiac Nomenclature Study Group, Working Group of Arrhythmias, European Society of Cardiology, and the Task Force on Cardiac Nomenclature from NASPE. Circulation. 1999; 100: e31e37.[Medline] [Order article via Infotrieve]
18. Anderson RH. The disposition and innervation of atrioventricular ring specialized tissue in rats and rabbits. J Anat. 1972; 113: 197211.[Medline] [Order article via Infotrieve]
19. Nikolski VP, Jones SA, Lancaster MK, Boyett MR, Efimov IR. Cx43 and dual-pathway electrophysiology of the atrioventricular node and atrioventricular nodal reentry. Circ Res. 2003; 92: 469475.
20. Petrecca K, Amellal F, Laird DW, Cohen SA, Shrier A. Sodium channel distribution within the rabbit atrioventricular node as analysed by confocal microscopy. J Physiol. 1997; 501: 263274.
21. Ko YS, Yeh HI, Ko YL, Hsu YC, Chen CF, Wu S, Lee YS, Severs NJ. Three-dimensional reconstruction of the rabbit atrioventricular conduction axis by combining histological, desmin, and connexin mapping data. Circulation. 2004; 109: 11721179.
22. Billette J. Atrioventricular nodal activation during periodic premature stimulation of the atrium. Am J Physiol. 1987; 252: H163H177.[Medline] [Order article via Infotrieve]
23. Mendez C, Moe GK. Demonstration of a dual A-V nodal conduction system in the isolated rabbit heart. Circ Res. 1966; 19: 378393.
24. Mazgalev TN, Ho SY, Anderson RH. Anatomic-electrophysiological correlations concerning the pathways for atrioventricular conduction. Circulation. 2001; 103: 26602667.
25. Mazgalev TN, Tchou PJ. Surface potentials from the region of the atrioventricular node and their relation to dual pathway electrophysiology. Circulation. 2000; 101: 21102117.
26. Patterson E, Scherlag BJ. Anatomic and functional fast atrioventricular conduction pathway. J Cardiovasc Electrophysiol. 2002; 13: 945949.[CrossRef][Medline] [Order article via Infotrieve]
27. Noujaim SF, Lucca E, Munoz V, Persaud D, Berenfeld O, Meijler FL, Jalife J. From mouse to whale: a universal scaling relation for the PR Interval of the electrocardiogram of mammals. Circulation. 2004; 110: 28022808.
28. Petrecca K, Shrier A. Spatial distribution of nerve processes and ß-adrenoreceptors in the rat atrioventricular node. J Anat. 1998; 192: 517528.[CrossRef][Medline] [Order article via Infotrieve]
29. Crick SJ, Wharton J, Sheppard MN, Royston D, Yacoub MH, Anderson RH, Polak JM. Innervation of the human cardiac conduction system: a quantitative immunohistochemical and histochemical study. Circulation. 1994; 89: 16971708.
30. Mutharasan RK, Nagaraj A, Hamilton AJ, McPherson DD, Bharati S. Computer three-dimensional reconstruction of the atrioventricular conduction system. Pacing Clin Electrophysiol. 2004; 27: 740748.[CrossRef][Medline] [Order article via Infotrieve]
| Footnotes |
|---|
Related Article:
Circulation 2006 114: 1343.
This article has been cited by other articles:
![]() |
M. R. Boyett \#8216;And the beat goes on' The cardiac conduction system: the wiring system of the heart Exp Physiol, October 1, 2009; 94(10): 1035 - 1049. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. D. Greener, J. O. Tellez, H. Dobrzynski, M. Yamamoto, G. M. Graham, R. Billeter, and M. R. Boyett Ion Channel Transcript Expression at the Rabbit Atrioventricular Conduction Axis Circ Arrhythm Electrophysiol, June 1, 2009; 2(3): 305 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J.D. Boukens, V. M. Christoffels, R. Coronel, and A. F.M. Moorman Developmental Basis for Electrophysiological Heterogeneity in the Ventricular and Outflow Tract Myocardium As a Substrate for Life-Threatening Ventricular Arrhythmias Circ. Res., January 2, 2009; 104(1): 19 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.H. Anderson, M.R. Boyett, H. Dobrzynski, J. Yanni, V.M. Christoffels, and A.F.M. Moorman Letter by Anderson et al Regarding Article, "Abnormal Conduction and Morphology in the Atrioventricular Node of Mice With Atrioventricular Canal-Targeted Deletion of Alk3/Bmpr1a Receptor" Circulation, August 5, 2008; 118(6): e105 - e105. [Full Text] [PDF] |
||||
![]() |
J. N. Dominguez, A. de la Rosa, F. Navarro, D. Franco, and A. E. Aranega Tissue distribution and subcellular localization of the cardiac sodium channel during mouse heart development Cardiovasc Res, April 1, 2008; 78(1): 45 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, V. Timofeyev, L. Lu, N. Li, A. Singapuri, M. K. Long, C. T. Bond, J. P. Adelman, and N. Chiamvimonvat Functional Roles of a Ca2+-Activated K+ Channel in Atrioventricular Nodes Circ. Res., February 29, 2008; 102(4): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel Roles and regulation of the cardiac sodium channel Nav1.5: Recent insights from experimental studies Cardiovasc Res, December 1, 2007; 76(3): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |